SlideShare uma empresa Scribd logo
1 de 10
Baixar para ler offline
4 Factors That Affect
Research Reproducibility
Improve Reproducibility in Your Lab by
Focusing on These Key Sources of Variability
WHITE PAPER
Getting on with Discovery
2
The fiery debate over reproducibility in science
has burned strong over the past several years,
and the flames don’t show any signs of dying
down just yet. No matter how scientists view
reproducibility in their respective fields — from
a full-blown crisis to a minor issue that doesn’t
impact the credibility of published findings —
the significance of reproducible experimental
design is undeniable.
All fields of science, immunology included,
were built on a foundation of replicating
experiments and studying breakthroughs
for expanding the knowledge base, inspiring
more experimentation, and ideally, leading
to additional breakthroughs. Without
reproducibility, the flywheel of experimentation
and discovery can’t gain momentum.
According to a Nature survey of 1,500 scientists,
more than 70% have tried and failed to
reproduce the results of another scientist’s
experiment, and perhaps more shocking and
concerning, over 50% have failed to reproduce
their own experiments.1
An Answer to the Problem?
Widespread reproducibility mandates have
been debated and undoubtedly would
be costly, time-consuming and difficult to
implement and enforce across the board.
While we await an industry-wide standard, if
one ever comes, there are many things we can
take responsibility for in our labs and research
practices to improve reproducibility.
We’ve outlined four of the primary sources of
variation in experimental results and provided
tips and research examples of how we’re
improving reproducibility in our immunology
and inflammation research lab.
4 Factors That Affect
Research Reproducibility
1.	 Reagents
2.	 Equipment
3.	 Personnel
4.	 Methods
Factor #1: Reagents
Antibodies and Cells
Verifying the quality of reagents used in research
can prevent wasted time, wasted resources and
unverifiable results. Unvalidated reagents can
snowball down the research chain, leading to
retracted publications and failures in pre-clinical
and clinical trials. Front-end validation, while
time-consuming, is an important step that many
researchers choose to skip without thinking
through the potential consequences.
Antibody quality control starts with procurement.
Look for a vendor that offers detailed product
documentation, has a substantial list of research
publications using their products and is
comfortable providing customer references.
The vendor should be able to provide test results
to show that the antibody binds to its target and
not to related proteins. This negative control is
as important as a positive control since cross-
reactivity is possible even with monoclonal
antibodies.
Check every product’s Certificate of Analysis
before making a purchase to confirm the purity
and viability of the cells and ensure the product
and donor specifications match your experimental
requirements. A good Certificate of Analysis will
be lot-specific to reflect testing of that particular
lot, not just a general product description.
3
Look for details like:
DDNumber of live cells per vial
DDPercentage of viable cells
DDExpression of cell surface antigens
(types of cells in the vial)
DDCell purity
DDDonor age
DDDonor gender
DDDonor race
DDDonor height
DDDonor weight
DDDonor blood type
DDDonor HLA type
Regardless of the product information given
by a vendor, always do your due diligence
by testing your antibodies and cell products
before starting your experiments to account for
discrepancies in the analysis and changes during
shipping, handling or storage. Test your products
using the technology you plan to use in your
experiment. If you will be using antibodies for
immunohistochemistry (IHC), test in IHC.
Culture Media
Culture media is an easily overlooked variable in
experimental design as researchers typically use
their favorite media or the one they deem most
appropriate for the experiment at hand. However,
differences in culture media environment can
have a major impact on cell behavior and thus
cause reproducibility issues.
The data in figures one and two show the
effect of culture medium on monocytes.
Human monocytes were cultured in either
DME/F12 or IMDM for five days. Both media were
supplemented with 10% human serum and
10 ng/mL recombinant human M-CSF. They were
then stimulated by the addition of 100 ng/mL LPS
and culture medium was collected after 48 hours.
The monocytes cultured in DME/F12 made more
IFNγ, IL-10, IL-6 and TNF-α, but the production of
IL-13 was equivalent in the two media.
600
500
400
300
200
100
0
Effect of Culture Medium on Production of Cytokines by Monocytes
pg/mLCytokine
IFN-γ IL-10 IL-13 IL-1β
DME/F12IMDM
Figure 1
IFNγ, IL-10, IL-13 and
IL-1β production
measured after culture
of monocytes in
DME/F12 and IMDM.
4
One way to reduce this variability is to use the
same culture media as described in the original
experiment when attempting to replicate a
research finding. However, not all culture media
are created equal.
When using serum-containing media, there
are natural variations in each animal’s genetics,
blood, environment and diet that create
extremely high lot-to-lot variability. Acquiring
enough serum from the same lot is challenging
Figure 2
IL-6 and TNF-α
production measured
after culture of
monocytes in DME/F12
and IMDM.
Figure 3
A medium designed to
be used without serum
was supplemented with
human serum or with
fetal calf serum and
used to support a T cell
proliferation assay. The
medium supplemented
with FCS supported
greater proliferation
at the highest peptide
concentration. The
medium that was not
supplemented allowed
greater proliferation
with low peptide
concentrations.
enough for a single researcher, and nearly
impossible for a scientist in another lab to acquire.
So what can you do? While fetal calf serum (FCS)
is a popular medium supplement, it does fall
victim to extreme variability. There are several
serum-free media on the market, which can
be great fits for your immunology experiments
and have far less variability. If FCS or other
serum-containing media are required, focus on
providing better documentation of your serum
selection and lot characteristics.
10,000
9,000
8,000
7,000
6,000
5,000
4,000
3,000
2,000
1,000
0
Effect of Culture Medium on IL-6 and TNF-α Productionpg/mLCytokine
IL-6 TNF-α
DME/F12IMDM
300,000
200,000
100,000
0
Proliferation of Tetanus Toxoid-Specific T Cells
RelativeLuminescenceUnits
0.001 0.01 0.1 1 10
µg/mL Peptide
Serum-Free Medium Medium + Human Serum Medium + Fetal Calf Serum
5
Factor #2: Equipment
Calibration
Lab equipment and instruments lose their
calibration over time, which can lead to
unreliable and imprecise results. An often
overlooked component of responsible
experimentation is making sure all equipment is
calibrated and capable of measuring its intended
results with accuracy, precision and safety.
Following a proper calibration schedule
will make your results more reliable and
reproducible. But how do you know if your
equipment is calibrated? And how often should
you check your equipment for accuracy?
Everything from your largest, most expensive
equipment to your smallest instruments should
be calibrated consistently to ensure proper
measurement. Reports should include the
calibration at the outset of measurements as
well as after adjustment. This habit will help
inform your calibration frequency and let you
know if your instruments are off. Follow these
suggestions for some popular lab equipment.
Equipment Calibration Frequency Suggestions
Biological Safety Cabinets
Incubators
Centrifuges
Manufacturer-recommended
calibration intervals or before
and after major experiments
Hire a metrologist to do a
professional, NIST-traceable
calibration
Pipettes
Biannual or before major
experiments
Test the full range of volume the
pipette can dispense
pH Meters Before every use
Refer to the original manual for
exact calibration standards
Precision vs Accuracy
Precision
Accuracy
Precision
Accuracy
Precision
Accuracy
Precision
Accuracy
6
Variation
Two different pieces of the same equipment are
going to differ — whether they are the same
model and year, or two models from different
decades. All equipment wears differently, even if
used for the same purposes over the same time
period in the same lab conditions.
Figures four and five show the difference
in measuring luminescence using two
microplate readers, a Packard Fusion™ and a
BioTek Synergy™ HT. The proliferation values as
measured by the Packard are lower but more
consistent within triplicates as shown by the
smaller error bars based on standard deviation.
The BioTek plate reader returned values that were
higher but also had a greater standard deviation
and coefficient of variation.
500,000
450,000
400,000
350,000
300,000
250,000
200,000
150,000
100,000
50,000
0
BC3 T Cell Proliferation
RelativeLuminescenceUnits
0 0.1 0.3 1 3 10
µg/mL Peptide
Figure 4
BC3 T cell proliferation
using a Packard Fusion™
microplate reader to
measure luminescence.
Figure 5
BC3 T cell proliferation
using a BioTek Synergy™
microplate reader to
measure luminescence.
500,000
450,000
400,000
350,000
300,000
250,000
200,000
150,000
100,000
50,000
0
BC3 T Cell Proliferation
RelativeLuminescenceUnits
0 30.3 1
µg/mL Peptide
7
The first step in controlling machine-to-machine
variation is to follow a consistent calibration
schedule. Beyond calibration, there are a few
things you can do to reduce the impacts of
equipment variability.
1.	 Contain your experiments to one set of
equipment. If your lab has two incubators,
for example, keep all of your samples for
one experiment in the same incubator.
This will eliminate any variability from
jumping back and forth between machines
throughout the study. We even see variation
in evaporation from the front to the back of
the incubator, so keep positioning in mind.
2.	 Provide thorough documentation.
Always note which equipment you used in
your methods, from the brand, model and
serial numbers to the date of last calibration
and any other pertinent information. Since
equipment is a likely source of variation
between labs, it should be noted.
3.	 Understand the idiosyncrasies of each
machine. Realize that each machine can
give slightly different results. For example,
a used microplate reader for luminescence
may give lower values than a new machine.
Understand these differences and know
how to account for them within and
between experiments.
Also be selective when making new equipment
purchases to be sure you’re getting the best
available product for your budget from a reputable
vendor that offers a reasonable warranty.
Buying used equipment can be a major cost
savings if you know what to look for. When
evaluating previously owned lab equipment, do
your research and ask the right questions.
DDHow long has the equipment been in use
and in what capacity?
DDDoes the machine have a history of
damage or refurbishment?
DDWhat are the terms of the warranty? Even
used equipment should have a warranty.
Factor #3: Personnel
Training and Mentorship
Ensure every researcher under your management
is adequately trained in experimental design.
Provide training and establish design standards
to which everyone must adhere.
Every scientist has an individual style when
executing even the simplest procedures, like
pipetting liquids, mixing solutions or counting
cells. Draw attention to those differences by
comparing results and discussing the reasons
for any discrepancies. This hands-on approach,
coupled with basic lab-wide standardization
guidelines, will help your scientists appreciate
the proper procedures.
Beyond training, put in place an expectation and
foundation of strong mentorship from senior
researchers. This is usually built into the hierarchy
in larger labs. In smaller research labs, mentorship
needs to come from the top. Owners, managers
or experienced scientists should make a
concerted, defined effort to understand
the professional goals of each researcher,
identify their strengths and opportunities for
improvement and set aside time to work with
each individual to advance their knowledge,
skills and confidence.
Researchers who feel valued and are given the
tools they need to succeed will be more fruitful
and loyal in the long term.
8
Statistical Analysis
Researchers too often fall into the trap of
sensationalizing conclusions with the goal
of publishing their works in high-visibility,
prestigious journals. This can lead to cherry-
picking results that, while promising or
interesting, may not be reproducible.
If you have a sound hypothesis, your experiments
are properly designed and executed and you
stick to the original intent of your research, your
results should speak for themselves and garner
the attention they deserve.
In Nature’s survey, nearly 90% of respondents
endorsed“better understanding of statistics,”
“better monitoring/supervision”and“more
robust design”as the top approaches to boost
reproducibility in science.
“Being at the cutting edge of science
means that sometimes results will not
be robust. We want to be discovering
new things but not generating too
many false leads.”
Marcus Munafo, a biological psychologist
at the University of Bristol, UK
Factor #4: Methods
Variation in Cell-Based Assays
Cell-based assays, when developed and
executed correctly, are an important tool in the
drug discovery process that can confirm how a
drug candidate interacts with and responds to
an organism. It’s important to follow the assay
instructions closely and use the materials and
methods exactly as described, otherwise risk
errors or unreliable outputs.
Cell-based assays have a much higher potential
for variation than a chemical assay due to the
nature of the immune system. Understanding
the degree of variability in a cell-based assay
and the sources of it will help researchers
account for inherent variations in the assay to
avoid improper conclusions.
Here are three common factors that should be
carefully controlled to reduce variability in any
cell-based assay.
DDSelecting Cells
Cell type will affect the conditions and
outcomes of the assay. There are major
differences between primary cells and cell
lines that make each suitable for different
types of assays. Follow the kit instructions
or protocol carefully and procure the ideal
cell type to ensure proper measurement.
DDPipetting Accuracy
Pipetting errors are very common and
can lead to false data. It’s important to
calibrate your pipette instruments and
follow proper techniques to ensure even
distribution in all wells.
DDControlling Edge Effects
Edge effects are errors resulting from
uneven distribution of cells in a well
plate, where cells in inner wells are
exposed to different conditions than
those in outer wells. The causes are many,
including evaporation during incubation,
temperature control and plate stacking.
Researchers have concluded that simple
changes, such as pre-incubation of newly
seeded plates at room temperature, can
reduce edge effects.2
9
Inconsistent Methods
Methods and measurement should be carefully
considered and tailored to each experiment. Any
changes in methods or measurement techniques
can yield inconsistent results, whether in your lab
or in others.
One common example of inconsistent methods
impacting results is measuring cell proliferation.
When using CellTiter-Glo®, a reagent based on
ATP content, increased cell metabolism and
higher ATP per cell is interpreted as proliferation.
However, increased cell metabolism can also
increase ATP per cell, which may complicate
interpretation.
If measuring proliferation with the uptake of
3H-thymidine or bromodeoxyuridine, which
label cells replicating their DNA, only the cells
in S phase will be labeled. These two methods
can produce vastly different results, especially
with immune cell populations in which a small
subset may proliferate with the majority simply
maintaining their metabolism.
Figure 6
PBMC proliferation
measured by ATP
content using
CellTiter-Glo®.
40,000
35,000
30,000
25,000
20,000
15,000
10,000
5,000
0
Proliferation Measured by ATP
RelativeLuminescenceUnits
Control Tetanus PHA LPS CMV
1406JN12 1559JY12
Figure 7
PBMC proliferation
measured by uptake of
bromodeoxyuridine.1.600
1.400
1.200
1.000
0.800
0.600
0.400
0.200
0.000
Proliferation Measured by BrdU Uptake
Absorbanceat450nm
Control Tetanus PHA LPS CMV
1406JN12 1559JY12
10
We also see differences in the amount of
cytokines measured using ELISA versus the Meso
Scale method, as a second example. This can
be traced, in some cases, to the nature of the
cytokine used to prepare the standard curve and
the accuracy of its concentration.
Another variable that should be carefully
selected is the analysis software. While several
tools may be designed with the same basic
principles and analytic concepts, each could
return different results when analyzing the same
dataset. Flow cytometry hardware combined
with software can increase or decrease sensitivity
of detection for rare cell types. Consider using
more than one type of software to get a better
picture of your full dataset.
Beefing up your design standards, method
selection and measurement techniques will not
only increase your intra-lab reproducibility but
should help outside scientists replicate your
findings as well.
Conclusion
Depending on the size of your lab and type of
research you perform, sweeping overhauls in the
way you run your lab and design experiments
may or may not be necessary. Only you can be
the judge of your needs.
However, you should be conscious of your
responsibility to publish reproducible findings
or deliver valid data to your customers. Even
implementing some of the suggestions
mentioned above could give your research a
significant boost in reproducibility.
References
1
Baker M. 1,500 Scientists Lift the Lid on Reproducibility.
Nature. 2016.
2
Lundholt B, Pagliaro L, Scudder K. A Sample Technique for
Reducing Edge Effect in Cell-Based Assays. J. Biomol. Screen.
2003; 8: 566-70.
Getting on with Discovery
866-513-1894 | www.astartebio.com
© Astarte Biologics, Inc.

Mais conteúdo relacionado

Mais procurados

Does your cell line have a secret? Avoid surprises with characterization
Does your cell line have a secret? Avoid surprises with characterizationDoes your cell line have a secret? Avoid surprises with characterization
Does your cell line have a secret? Avoid surprises with characterizationMerck Life Sciences
 
Accelerating Usp
Accelerating UspAccelerating Usp
Accelerating UspSMEbiotech
 
Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...
Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...
Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...Merck Life Sciences
 
Setting up for successful lot release testing by Edmund Ang
Setting up for successful lot release testing by Edmund AngSetting up for successful lot release testing by Edmund Ang
Setting up for successful lot release testing by Edmund AngMilliporeSigma
 
Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...
Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...
Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...Merck Life Sciences
 
Nicheoutsourcing
NicheoutsourcingNicheoutsourcing
NicheoutsourcingSMEbiotech
 
Presentation of Frank Hills in 1st International Antibody Validation Forum 2014
Presentation of Frank Hills in 1st International Antibody Validation Forum 2014Presentation of Frank Hills in 1st International Antibody Validation Forum 2014
Presentation of Frank Hills in 1st International Antibody Validation Forum 2014St John's Laboratory Ltd
 
Immune Monitoring
Immune MonitoringImmune Monitoring
Immune MonitoringPamoja
 
Unveiling the Potential of your AAV Gene Therapy: Orthogonal methods to under...
Unveiling the Potential of your AAV Gene Therapy: Orthogonal methods to under...Unveiling the Potential of your AAV Gene Therapy: Orthogonal methods to under...
Unveiling the Potential of your AAV Gene Therapy: Orthogonal methods to under...Merck Life Sciences
 
Platform Technologies to Accelerate Novel Vaccine Development and Manufacturing
Platform Technologies to Accelerate Novel Vaccine Development and ManufacturingPlatform Technologies to Accelerate Novel Vaccine Development and Manufacturing
Platform Technologies to Accelerate Novel Vaccine Development and ManufacturingMerck Life Sciences
 
Development of Production and Purification Platformform for Influenza Vaccine
Development of Production and Purification Platformform for Influenza VaccineDevelopment of Production and Purification Platformform for Influenza Vaccine
Development of Production and Purification Platformform for Influenza VaccineDr. Priyabrata Pattnaik
 
Presentation of John Mountzouris in 1st International Antibody Validation For...
Presentation of John Mountzouris in 1st International Antibody Validation For...Presentation of John Mountzouris in 1st International Antibody Validation For...
Presentation of John Mountzouris in 1st International Antibody Validation For...St John's Laboratory Ltd
 
IBT Bioservices Capabilities
IBT Bioservices CapabilitiesIBT Bioservices Capabilities
IBT Bioservices CapabilitiesTodd Pelham
 
Presentation of Andrew Chalmers in 1st International Antibody Validation For...
Presentation of  Andrew Chalmers in 1st International Antibody Validation For...Presentation of  Andrew Chalmers in 1st International Antibody Validation For...
Presentation of Andrew Chalmers in 1st International Antibody Validation For...St John's Laboratory Ltd
 

Mais procurados (16)

Does your cell line have a secret? Avoid surprises with characterization
Does your cell line have a secret? Avoid surprises with characterizationDoes your cell line have a secret? Avoid surprises with characterization
Does your cell line have a secret? Avoid surprises with characterization
 
Accelerating Usp
Accelerating UspAccelerating Usp
Accelerating Usp
 
Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...
Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...
Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...
 
Setting up for successful lot release testing by Edmund Ang
Setting up for successful lot release testing by Edmund AngSetting up for successful lot release testing by Edmund Ang
Setting up for successful lot release testing by Edmund Ang
 
Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...
Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...
Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...
 
Nicheoutsourcing
NicheoutsourcingNicheoutsourcing
Nicheoutsourcing
 
Presentation of Frank Hills in 1st International Antibody Validation Forum 2014
Presentation of Frank Hills in 1st International Antibody Validation Forum 2014Presentation of Frank Hills in 1st International Antibody Validation Forum 2014
Presentation of Frank Hills in 1st International Antibody Validation Forum 2014
 
Immune Monitoring
Immune MonitoringImmune Monitoring
Immune Monitoring
 
Tetanus toxoid paper
Tetanus toxoid paperTetanus toxoid paper
Tetanus toxoid paper
 
Unveiling the Potential of your AAV Gene Therapy: Orthogonal methods to under...
Unveiling the Potential of your AAV Gene Therapy: Orthogonal methods to under...Unveiling the Potential of your AAV Gene Therapy: Orthogonal methods to under...
Unveiling the Potential of your AAV Gene Therapy: Orthogonal methods to under...
 
Platform Technologies to Accelerate Novel Vaccine Development and Manufacturing
Platform Technologies to Accelerate Novel Vaccine Development and ManufacturingPlatform Technologies to Accelerate Novel Vaccine Development and Manufacturing
Platform Technologies to Accelerate Novel Vaccine Development and Manufacturing
 
Development of Production and Purification Platformform for Influenza Vaccine
Development of Production and Purification Platformform for Influenza VaccineDevelopment of Production and Purification Platformform for Influenza Vaccine
Development of Production and Purification Platformform for Influenza Vaccine
 
Presentation of John Mountzouris in 1st International Antibody Validation For...
Presentation of John Mountzouris in 1st International Antibody Validation For...Presentation of John Mountzouris in 1st International Antibody Validation For...
Presentation of John Mountzouris in 1st International Antibody Validation For...
 
IBT Bioservices Capabilities
IBT Bioservices CapabilitiesIBT Bioservices Capabilities
IBT Bioservices Capabilities
 
TestGene catalogue
TestGene catalogueTestGene catalogue
TestGene catalogue
 
Presentation of Andrew Chalmers in 1st International Antibody Validation For...
Presentation of  Andrew Chalmers in 1st International Antibody Validation For...Presentation of  Andrew Chalmers in 1st International Antibody Validation For...
Presentation of Andrew Chalmers in 1st International Antibody Validation For...
 

Semelhante a 4 Factors That Affect Research Reproducibility

MDC Connects: Go native… Characterising therapeutic effect in primary cellula...
MDC Connects: Go native… Characterising therapeutic effect in primary cellula...MDC Connects: Go native… Characterising therapeutic effect in primary cellula...
MDC Connects: Go native… Characterising therapeutic effect in primary cellula...Medicines Discovery Catapult
 
Bioanalytical validation personal perspective
Bioanalytical validation personal perspectiveBioanalytical validation personal perspective
Bioanalytical validation personal perspectiveE. Dennis Bashaw
 
PEGS China 2015 Final Agenda
PEGS China 2015 Final AgendaPEGS China 2015 Final Agenda
PEGS China 2015 Final AgendaNicole Proulx
 
2010StanfordE25 Michele dragoescu e25 project
2010StanfordE25 Michele dragoescu e25 project2010StanfordE25 Michele dragoescu e25 project
2010StanfordE25 Michele dragoescu e25 projectmdragoescu
 
Personalized Medicine: Genetic Diagnostics Technologies
Personalized Medicine: Genetic Diagnostics TechnologiesPersonalized Medicine: Genetic Diagnostics Technologies
Personalized Medicine: Genetic Diagnostics TechnologiesMaRS Discovery District
 
pub_EBR_April-14_pp.10-14
pub_EBR_April-14_pp.10-14pub_EBR_April-14_pp.10-14
pub_EBR_April-14_pp.10-14biocision
 
Assignment on Alternatives to Animal Screening Method
Assignment on Alternatives to Animal Screening MethodAssignment on Alternatives to Animal Screening Method
Assignment on Alternatives to Animal Screening MethodDeepak Kumar
 
Cambridge Bioscience_ ACEA User Group Meeting2014
Cambridge Bioscience_ ACEA User Group Meeting2014Cambridge Bioscience_ ACEA User Group Meeting2014
Cambridge Bioscience_ ACEA User Group Meeting2014Jay Champaneri
 
CHI's Bioassays for Immuno-Oncology Symposium, Oct. 23, 2017 in Washington, DC
CHI's Bioassays for Immuno-Oncology Symposium, Oct. 23, 2017 in Washington, DCCHI's Bioassays for Immuno-Oncology Symposium, Oct. 23, 2017 in Washington, DC
CHI's Bioassays for Immuno-Oncology Symposium, Oct. 23, 2017 in Washington, DCJames Prudhomme
 
C&E news talk sept 16
C&E news talk sept 16C&E news talk sept 16
C&E news talk sept 16Sean Ekins
 
Neuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport MediaNeuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport MediaPete Shuster
 
Vanderwall cheminformatics Drexel Part 1
Vanderwall cheminformatics Drexel Part 1Vanderwall cheminformatics Drexel Part 1
Vanderwall cheminformatics Drexel Part 1Jean-Claude Bradley
 
PEGS Europe Protein & Antibody Engineering Summit 2014 Agenda
PEGS Europe Protein & Antibody Engineering Summit 2014 AgendaPEGS Europe Protein & Antibody Engineering Summit 2014 Agenda
PEGS Europe Protein & Antibody Engineering Summit 2014 AgendaNicole Proulx
 
Stem Cells: A Dynamic Landscape
Stem Cells: A Dynamic LandscapeStem Cells: A Dynamic Landscape
Stem Cells: A Dynamic LandscapeCovance
 
PEGS China-2016-Brochure
PEGS China-2016-BrochurePEGS China-2016-Brochure
PEGS China-2016-BrochureNicole Proulx
 
From In Silco to In Vivo – Modeling and Simulation Technologies, a Tool for O...
From In Silco to In Vivo – Modeling and Simulation Technologies, a Tool for O...From In Silco to In Vivo – Modeling and Simulation Technologies, a Tool for O...
From In Silco to In Vivo – Modeling and Simulation Technologies, a Tool for O...Life Sciences Network marcus evans
 
IQT Quarterly Winter 2016 - Lim
IQT Quarterly Winter 2016 - LimIQT Quarterly Winter 2016 - Lim
IQT Quarterly Winter 2016 - LimMark David Lim
 

Semelhante a 4 Factors That Affect Research Reproducibility (20)

MDC Connects: Go native… Characterising therapeutic effect in primary cellula...
MDC Connects: Go native… Characterising therapeutic effect in primary cellula...MDC Connects: Go native… Characterising therapeutic effect in primary cellula...
MDC Connects: Go native… Characterising therapeutic effect in primary cellula...
 
Bioanalytical validation personal perspective
Bioanalytical validation personal perspectiveBioanalytical validation personal perspective
Bioanalytical validation personal perspective
 
PEGS China 2015 Final Agenda
PEGS China 2015 Final AgendaPEGS China 2015 Final Agenda
PEGS China 2015 Final Agenda
 
2010StanfordE25 Michele dragoescu e25 project
2010StanfordE25 Michele dragoescu e25 project2010StanfordE25 Michele dragoescu e25 project
2010StanfordE25 Michele dragoescu e25 project
 
Personalized Medicine: Genetic Diagnostics Technologies
Personalized Medicine: Genetic Diagnostics TechnologiesPersonalized Medicine: Genetic Diagnostics Technologies
Personalized Medicine: Genetic Diagnostics Technologies
 
pub_EBR_April-14_pp.10-14
pub_EBR_April-14_pp.10-14pub_EBR_April-14_pp.10-14
pub_EBR_April-14_pp.10-14
 
pub_EBR_April-14_pp.10-14
pub_EBR_April-14_pp.10-14pub_EBR_April-14_pp.10-14
pub_EBR_April-14_pp.10-14
 
Assignment on Alternatives to Animal Screening Method
Assignment on Alternatives to Animal Screening MethodAssignment on Alternatives to Animal Screening Method
Assignment on Alternatives to Animal Screening Method
 
Cambridge Bioscience_ ACEA User Group Meeting2014
Cambridge Bioscience_ ACEA User Group Meeting2014Cambridge Bioscience_ ACEA User Group Meeting2014
Cambridge Bioscience_ ACEA User Group Meeting2014
 
CHI's Bioassays for Immuno-Oncology Symposium, Oct. 23, 2017 in Washington, DC
CHI's Bioassays for Immuno-Oncology Symposium, Oct. 23, 2017 in Washington, DCCHI's Bioassays for Immuno-Oncology Symposium, Oct. 23, 2017 in Washington, DC
CHI's Bioassays for Immuno-Oncology Symposium, Oct. 23, 2017 in Washington, DC
 
C&E news talk sept 16
C&E news talk sept 16C&E news talk sept 16
C&E news talk sept 16
 
Neuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport MediaNeuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport Media
 
Vanderwall cheminformatics Drexel Part 1
Vanderwall cheminformatics Drexel Part 1Vanderwall cheminformatics Drexel Part 1
Vanderwall cheminformatics Drexel Part 1
 
PEGS Europe Protein & Antibody Engineering Summit 2014 Agenda
PEGS Europe Protein & Antibody Engineering Summit 2014 AgendaPEGS Europe Protein & Antibody Engineering Summit 2014 Agenda
PEGS Europe Protein & Antibody Engineering Summit 2014 Agenda
 
Stem Cells: A Dynamic Landscape
Stem Cells: A Dynamic LandscapeStem Cells: A Dynamic Landscape
Stem Cells: A Dynamic Landscape
 
FTEC 492 Poster
FTEC 492 PosterFTEC 492 Poster
FTEC 492 Poster
 
PEGS China-2016-Brochure
PEGS China-2016-BrochurePEGS China-2016-Brochure
PEGS China-2016-Brochure
 
From In Silco to In Vivo – Modeling and Simulation Technologies, a Tool for O...
From In Silco to In Vivo – Modeling and Simulation Technologies, a Tool for O...From In Silco to In Vivo – Modeling and Simulation Technologies, a Tool for O...
From In Silco to In Vivo – Modeling and Simulation Technologies, a Tool for O...
 
CliniMACS newsletter 2011
CliniMACS newsletter 2011CliniMACS newsletter 2011
CliniMACS newsletter 2011
 
IQT Quarterly Winter 2016 - Lim
IQT Quarterly Winter 2016 - LimIQT Quarterly Winter 2016 - Lim
IQT Quarterly Winter 2016 - Lim
 

Mais de Cellero

Measuring Cell-Mediated Cytotoxicity
Measuring Cell-Mediated CytotoxicityMeasuring Cell-Mediated Cytotoxicity
Measuring Cell-Mediated CytotoxicityCellero
 
Strategies for Accurately Measuring Cell-Mediated Cytotoxicity
Strategies for Accurately Measuring Cell-Mediated CytotoxicityStrategies for Accurately Measuring Cell-Mediated Cytotoxicity
Strategies for Accurately Measuring Cell-Mediated CytotoxicityCellero
 
Measuring Immune Cell Activation - Webinar
Measuring Immune Cell Activation - WebinarMeasuring Immune Cell Activation - Webinar
Measuring Immune Cell Activation - WebinarCellero
 
Progenitor vs.CD34+ Cells Infographic
Progenitor vs.CD34+ Cells InfographicProgenitor vs.CD34+ Cells Infographic
Progenitor vs.CD34+ Cells InfographicCellero
 
Comparison of Culture Media for In Vitro T Cell Expansion & Function
Comparison of Culture Media for In Vitro T Cell Expansion & FunctionComparison of Culture Media for In Vitro T Cell Expansion & Function
Comparison of Culture Media for In Vitro T Cell Expansion & FunctionCellero
 
4 Factors That Affect Research Reproducibility
4 Factors That Affect Research Reproducibility4 Factors That Affect Research Reproducibility
4 Factors That Affect Research ReproducibilityCellero
 
CFDA-SE Labeling Protocol
CFDA-SE Labeling ProtocolCFDA-SE Labeling Protocol
CFDA-SE Labeling ProtocolCellero
 
A Blood Shortage Crisis
A Blood Shortage CrisisA Blood Shortage Crisis
A Blood Shortage CrisisCellero
 
Using a Recall Antigen Assay as a Tool for Understanding Immunity: A Case Study
Using a Recall Antigen Assay as a Tool for Understanding Immunity: A Case StudyUsing a Recall Antigen Assay as a Tool for Understanding Immunity: A Case Study
Using a Recall Antigen Assay as a Tool for Understanding Immunity: A Case StudyCellero
 

Mais de Cellero (9)

Measuring Cell-Mediated Cytotoxicity
Measuring Cell-Mediated CytotoxicityMeasuring Cell-Mediated Cytotoxicity
Measuring Cell-Mediated Cytotoxicity
 
Strategies for Accurately Measuring Cell-Mediated Cytotoxicity
Strategies for Accurately Measuring Cell-Mediated CytotoxicityStrategies for Accurately Measuring Cell-Mediated Cytotoxicity
Strategies for Accurately Measuring Cell-Mediated Cytotoxicity
 
Measuring Immune Cell Activation - Webinar
Measuring Immune Cell Activation - WebinarMeasuring Immune Cell Activation - Webinar
Measuring Immune Cell Activation - Webinar
 
Progenitor vs.CD34+ Cells Infographic
Progenitor vs.CD34+ Cells InfographicProgenitor vs.CD34+ Cells Infographic
Progenitor vs.CD34+ Cells Infographic
 
Comparison of Culture Media for In Vitro T Cell Expansion & Function
Comparison of Culture Media for In Vitro T Cell Expansion & FunctionComparison of Culture Media for In Vitro T Cell Expansion & Function
Comparison of Culture Media for In Vitro T Cell Expansion & Function
 
4 Factors That Affect Research Reproducibility
4 Factors That Affect Research Reproducibility4 Factors That Affect Research Reproducibility
4 Factors That Affect Research Reproducibility
 
CFDA-SE Labeling Protocol
CFDA-SE Labeling ProtocolCFDA-SE Labeling Protocol
CFDA-SE Labeling Protocol
 
A Blood Shortage Crisis
A Blood Shortage CrisisA Blood Shortage Crisis
A Blood Shortage Crisis
 
Using a Recall Antigen Assay as a Tool for Understanding Immunity: A Case Study
Using a Recall Antigen Assay as a Tool for Understanding Immunity: A Case StudyUsing a Recall Antigen Assay as a Tool for Understanding Immunity: A Case Study
Using a Recall Antigen Assay as a Tool for Understanding Immunity: A Case Study
 

Último

Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisRaman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisDiwakar Mishra
 
Presentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxPresentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxgindu3009
 
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bAsymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bSérgio Sacani
 
Zoology 4th semester series (krishna).pdf
Zoology 4th semester series (krishna).pdfZoology 4th semester series (krishna).pdf
Zoology 4th semester series (krishna).pdfSumit Kumar yadav
 
Pests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdfPests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdfPirithiRaju
 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...RohitNehra6
 
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.Nitya salvi
 
Hire 💕 9907093804 Hooghly Call Girls Service Call Girls Agency
Hire 💕 9907093804 Hooghly Call Girls Service Call Girls AgencyHire 💕 9907093804 Hooghly Call Girls Service Call Girls Agency
Hire 💕 9907093804 Hooghly Call Girls Service Call Girls AgencySheetal Arora
 
Biological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfBiological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfmuntazimhurra
 
TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...
TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...
TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...ssifa0344
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bSérgio Sacani
 
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdf
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdfPests of cotton_Borer_Pests_Binomics_Dr.UPR.pdf
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdfPirithiRaju
 
Nanoparticles synthesis and characterization​ ​
Nanoparticles synthesis and characterization​  ​Nanoparticles synthesis and characterization​  ​
Nanoparticles synthesis and characterization​ ​kaibalyasahoo82800
 
GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)Areesha Ahmad
 
9654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 6000
9654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 60009654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 6000
9654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 6000Sapana Sha
 
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...Sérgio Sacani
 
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Sérgio Sacani
 
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSpermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSarthak Sekhar Mondal
 
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...anilsa9823
 

Último (20)

Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisRaman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
 
Presentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxPresentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptx
 
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bAsymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
 
Zoology 4th semester series (krishna).pdf
Zoology 4th semester series (krishna).pdfZoology 4th semester series (krishna).pdf
Zoology 4th semester series (krishna).pdf
 
Pests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdfPests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdf
 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...
 
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
 
Hire 💕 9907093804 Hooghly Call Girls Service Call Girls Agency
Hire 💕 9907093804 Hooghly Call Girls Service Call Girls AgencyHire 💕 9907093804 Hooghly Call Girls Service Call Girls Agency
Hire 💕 9907093804 Hooghly Call Girls Service Call Girls Agency
 
The Philosophy of Science
The Philosophy of ScienceThe Philosophy of Science
The Philosophy of Science
 
Biological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfBiological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdf
 
TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...
TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...
TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
 
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdf
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdfPests of cotton_Borer_Pests_Binomics_Dr.UPR.pdf
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdf
 
Nanoparticles synthesis and characterization​ ​
Nanoparticles synthesis and characterization​  ​Nanoparticles synthesis and characterization​  ​
Nanoparticles synthesis and characterization​ ​
 
GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)
 
9654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 6000
9654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 60009654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 6000
9654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 6000
 
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
 
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
 
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSpermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
 
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
 

4 Factors That Affect Research Reproducibility

  • 1. 4 Factors That Affect Research Reproducibility Improve Reproducibility in Your Lab by Focusing on These Key Sources of Variability WHITE PAPER Getting on with Discovery
  • 2. 2 The fiery debate over reproducibility in science has burned strong over the past several years, and the flames don’t show any signs of dying down just yet. No matter how scientists view reproducibility in their respective fields — from a full-blown crisis to a minor issue that doesn’t impact the credibility of published findings — the significance of reproducible experimental design is undeniable. All fields of science, immunology included, were built on a foundation of replicating experiments and studying breakthroughs for expanding the knowledge base, inspiring more experimentation, and ideally, leading to additional breakthroughs. Without reproducibility, the flywheel of experimentation and discovery can’t gain momentum. According to a Nature survey of 1,500 scientists, more than 70% have tried and failed to reproduce the results of another scientist’s experiment, and perhaps more shocking and concerning, over 50% have failed to reproduce their own experiments.1 An Answer to the Problem? Widespread reproducibility mandates have been debated and undoubtedly would be costly, time-consuming and difficult to implement and enforce across the board. While we await an industry-wide standard, if one ever comes, there are many things we can take responsibility for in our labs and research practices to improve reproducibility. We’ve outlined four of the primary sources of variation in experimental results and provided tips and research examples of how we’re improving reproducibility in our immunology and inflammation research lab. 4 Factors That Affect Research Reproducibility 1. Reagents 2. Equipment 3. Personnel 4. Methods Factor #1: Reagents Antibodies and Cells Verifying the quality of reagents used in research can prevent wasted time, wasted resources and unverifiable results. Unvalidated reagents can snowball down the research chain, leading to retracted publications and failures in pre-clinical and clinical trials. Front-end validation, while time-consuming, is an important step that many researchers choose to skip without thinking through the potential consequences. Antibody quality control starts with procurement. Look for a vendor that offers detailed product documentation, has a substantial list of research publications using their products and is comfortable providing customer references. The vendor should be able to provide test results to show that the antibody binds to its target and not to related proteins. This negative control is as important as a positive control since cross- reactivity is possible even with monoclonal antibodies. Check every product’s Certificate of Analysis before making a purchase to confirm the purity and viability of the cells and ensure the product and donor specifications match your experimental requirements. A good Certificate of Analysis will be lot-specific to reflect testing of that particular lot, not just a general product description.
  • 3. 3 Look for details like: DDNumber of live cells per vial DDPercentage of viable cells DDExpression of cell surface antigens (types of cells in the vial) DDCell purity DDDonor age DDDonor gender DDDonor race DDDonor height DDDonor weight DDDonor blood type DDDonor HLA type Regardless of the product information given by a vendor, always do your due diligence by testing your antibodies and cell products before starting your experiments to account for discrepancies in the analysis and changes during shipping, handling or storage. Test your products using the technology you plan to use in your experiment. If you will be using antibodies for immunohistochemistry (IHC), test in IHC. Culture Media Culture media is an easily overlooked variable in experimental design as researchers typically use their favorite media or the one they deem most appropriate for the experiment at hand. However, differences in culture media environment can have a major impact on cell behavior and thus cause reproducibility issues. The data in figures one and two show the effect of culture medium on monocytes. Human monocytes were cultured in either DME/F12 or IMDM for five days. Both media were supplemented with 10% human serum and 10 ng/mL recombinant human M-CSF. They were then stimulated by the addition of 100 ng/mL LPS and culture medium was collected after 48 hours. The monocytes cultured in DME/F12 made more IFNγ, IL-10, IL-6 and TNF-α, but the production of IL-13 was equivalent in the two media. 600 500 400 300 200 100 0 Effect of Culture Medium on Production of Cytokines by Monocytes pg/mLCytokine IFN-γ IL-10 IL-13 IL-1β DME/F12IMDM Figure 1 IFNγ, IL-10, IL-13 and IL-1β production measured after culture of monocytes in DME/F12 and IMDM.
  • 4. 4 One way to reduce this variability is to use the same culture media as described in the original experiment when attempting to replicate a research finding. However, not all culture media are created equal. When using serum-containing media, there are natural variations in each animal’s genetics, blood, environment and diet that create extremely high lot-to-lot variability. Acquiring enough serum from the same lot is challenging Figure 2 IL-6 and TNF-α production measured after culture of monocytes in DME/F12 and IMDM. Figure 3 A medium designed to be used without serum was supplemented with human serum or with fetal calf serum and used to support a T cell proliferation assay. The medium supplemented with FCS supported greater proliferation at the highest peptide concentration. The medium that was not supplemented allowed greater proliferation with low peptide concentrations. enough for a single researcher, and nearly impossible for a scientist in another lab to acquire. So what can you do? While fetal calf serum (FCS) is a popular medium supplement, it does fall victim to extreme variability. There are several serum-free media on the market, which can be great fits for your immunology experiments and have far less variability. If FCS or other serum-containing media are required, focus on providing better documentation of your serum selection and lot characteristics. 10,000 9,000 8,000 7,000 6,000 5,000 4,000 3,000 2,000 1,000 0 Effect of Culture Medium on IL-6 and TNF-α Productionpg/mLCytokine IL-6 TNF-α DME/F12IMDM 300,000 200,000 100,000 0 Proliferation of Tetanus Toxoid-Specific T Cells RelativeLuminescenceUnits 0.001 0.01 0.1 1 10 µg/mL Peptide Serum-Free Medium Medium + Human Serum Medium + Fetal Calf Serum
  • 5. 5 Factor #2: Equipment Calibration Lab equipment and instruments lose their calibration over time, which can lead to unreliable and imprecise results. An often overlooked component of responsible experimentation is making sure all equipment is calibrated and capable of measuring its intended results with accuracy, precision and safety. Following a proper calibration schedule will make your results more reliable and reproducible. But how do you know if your equipment is calibrated? And how often should you check your equipment for accuracy? Everything from your largest, most expensive equipment to your smallest instruments should be calibrated consistently to ensure proper measurement. Reports should include the calibration at the outset of measurements as well as after adjustment. This habit will help inform your calibration frequency and let you know if your instruments are off. Follow these suggestions for some popular lab equipment. Equipment Calibration Frequency Suggestions Biological Safety Cabinets Incubators Centrifuges Manufacturer-recommended calibration intervals or before and after major experiments Hire a metrologist to do a professional, NIST-traceable calibration Pipettes Biannual or before major experiments Test the full range of volume the pipette can dispense pH Meters Before every use Refer to the original manual for exact calibration standards Precision vs Accuracy Precision Accuracy Precision Accuracy Precision Accuracy Precision Accuracy
  • 6. 6 Variation Two different pieces of the same equipment are going to differ — whether they are the same model and year, or two models from different decades. All equipment wears differently, even if used for the same purposes over the same time period in the same lab conditions. Figures four and five show the difference in measuring luminescence using two microplate readers, a Packard Fusion™ and a BioTek Synergy™ HT. The proliferation values as measured by the Packard are lower but more consistent within triplicates as shown by the smaller error bars based on standard deviation. The BioTek plate reader returned values that were higher but also had a greater standard deviation and coefficient of variation. 500,000 450,000 400,000 350,000 300,000 250,000 200,000 150,000 100,000 50,000 0 BC3 T Cell Proliferation RelativeLuminescenceUnits 0 0.1 0.3 1 3 10 µg/mL Peptide Figure 4 BC3 T cell proliferation using a Packard Fusion™ microplate reader to measure luminescence. Figure 5 BC3 T cell proliferation using a BioTek Synergy™ microplate reader to measure luminescence. 500,000 450,000 400,000 350,000 300,000 250,000 200,000 150,000 100,000 50,000 0 BC3 T Cell Proliferation RelativeLuminescenceUnits 0 30.3 1 µg/mL Peptide
  • 7. 7 The first step in controlling machine-to-machine variation is to follow a consistent calibration schedule. Beyond calibration, there are a few things you can do to reduce the impacts of equipment variability. 1. Contain your experiments to one set of equipment. If your lab has two incubators, for example, keep all of your samples for one experiment in the same incubator. This will eliminate any variability from jumping back and forth between machines throughout the study. We even see variation in evaporation from the front to the back of the incubator, so keep positioning in mind. 2. Provide thorough documentation. Always note which equipment you used in your methods, from the brand, model and serial numbers to the date of last calibration and any other pertinent information. Since equipment is a likely source of variation between labs, it should be noted. 3. Understand the idiosyncrasies of each machine. Realize that each machine can give slightly different results. For example, a used microplate reader for luminescence may give lower values than a new machine. Understand these differences and know how to account for them within and between experiments. Also be selective when making new equipment purchases to be sure you’re getting the best available product for your budget from a reputable vendor that offers a reasonable warranty. Buying used equipment can be a major cost savings if you know what to look for. When evaluating previously owned lab equipment, do your research and ask the right questions. DDHow long has the equipment been in use and in what capacity? DDDoes the machine have a history of damage or refurbishment? DDWhat are the terms of the warranty? Even used equipment should have a warranty. Factor #3: Personnel Training and Mentorship Ensure every researcher under your management is adequately trained in experimental design. Provide training and establish design standards to which everyone must adhere. Every scientist has an individual style when executing even the simplest procedures, like pipetting liquids, mixing solutions or counting cells. Draw attention to those differences by comparing results and discussing the reasons for any discrepancies. This hands-on approach, coupled with basic lab-wide standardization guidelines, will help your scientists appreciate the proper procedures. Beyond training, put in place an expectation and foundation of strong mentorship from senior researchers. This is usually built into the hierarchy in larger labs. In smaller research labs, mentorship needs to come from the top. Owners, managers or experienced scientists should make a concerted, defined effort to understand the professional goals of each researcher, identify their strengths and opportunities for improvement and set aside time to work with each individual to advance their knowledge, skills and confidence. Researchers who feel valued and are given the tools they need to succeed will be more fruitful and loyal in the long term.
  • 8. 8 Statistical Analysis Researchers too often fall into the trap of sensationalizing conclusions with the goal of publishing their works in high-visibility, prestigious journals. This can lead to cherry- picking results that, while promising or interesting, may not be reproducible. If you have a sound hypothesis, your experiments are properly designed and executed and you stick to the original intent of your research, your results should speak for themselves and garner the attention they deserve. In Nature’s survey, nearly 90% of respondents endorsed“better understanding of statistics,” “better monitoring/supervision”and“more robust design”as the top approaches to boost reproducibility in science. “Being at the cutting edge of science means that sometimes results will not be robust. We want to be discovering new things but not generating too many false leads.” Marcus Munafo, a biological psychologist at the University of Bristol, UK Factor #4: Methods Variation in Cell-Based Assays Cell-based assays, when developed and executed correctly, are an important tool in the drug discovery process that can confirm how a drug candidate interacts with and responds to an organism. It’s important to follow the assay instructions closely and use the materials and methods exactly as described, otherwise risk errors or unreliable outputs. Cell-based assays have a much higher potential for variation than a chemical assay due to the nature of the immune system. Understanding the degree of variability in a cell-based assay and the sources of it will help researchers account for inherent variations in the assay to avoid improper conclusions. Here are three common factors that should be carefully controlled to reduce variability in any cell-based assay. DDSelecting Cells Cell type will affect the conditions and outcomes of the assay. There are major differences between primary cells and cell lines that make each suitable for different types of assays. Follow the kit instructions or protocol carefully and procure the ideal cell type to ensure proper measurement. DDPipetting Accuracy Pipetting errors are very common and can lead to false data. It’s important to calibrate your pipette instruments and follow proper techniques to ensure even distribution in all wells. DDControlling Edge Effects Edge effects are errors resulting from uneven distribution of cells in a well plate, where cells in inner wells are exposed to different conditions than those in outer wells. The causes are many, including evaporation during incubation, temperature control and plate stacking. Researchers have concluded that simple changes, such as pre-incubation of newly seeded plates at room temperature, can reduce edge effects.2
  • 9. 9 Inconsistent Methods Methods and measurement should be carefully considered and tailored to each experiment. Any changes in methods or measurement techniques can yield inconsistent results, whether in your lab or in others. One common example of inconsistent methods impacting results is measuring cell proliferation. When using CellTiter-Glo®, a reagent based on ATP content, increased cell metabolism and higher ATP per cell is interpreted as proliferation. However, increased cell metabolism can also increase ATP per cell, which may complicate interpretation. If measuring proliferation with the uptake of 3H-thymidine or bromodeoxyuridine, which label cells replicating their DNA, only the cells in S phase will be labeled. These two methods can produce vastly different results, especially with immune cell populations in which a small subset may proliferate with the majority simply maintaining their metabolism. Figure 6 PBMC proliferation measured by ATP content using CellTiter-Glo®. 40,000 35,000 30,000 25,000 20,000 15,000 10,000 5,000 0 Proliferation Measured by ATP RelativeLuminescenceUnits Control Tetanus PHA LPS CMV 1406JN12 1559JY12 Figure 7 PBMC proliferation measured by uptake of bromodeoxyuridine.1.600 1.400 1.200 1.000 0.800 0.600 0.400 0.200 0.000 Proliferation Measured by BrdU Uptake Absorbanceat450nm Control Tetanus PHA LPS CMV 1406JN12 1559JY12
  • 10. 10 We also see differences in the amount of cytokines measured using ELISA versus the Meso Scale method, as a second example. This can be traced, in some cases, to the nature of the cytokine used to prepare the standard curve and the accuracy of its concentration. Another variable that should be carefully selected is the analysis software. While several tools may be designed with the same basic principles and analytic concepts, each could return different results when analyzing the same dataset. Flow cytometry hardware combined with software can increase or decrease sensitivity of detection for rare cell types. Consider using more than one type of software to get a better picture of your full dataset. Beefing up your design standards, method selection and measurement techniques will not only increase your intra-lab reproducibility but should help outside scientists replicate your findings as well. Conclusion Depending on the size of your lab and type of research you perform, sweeping overhauls in the way you run your lab and design experiments may or may not be necessary. Only you can be the judge of your needs. However, you should be conscious of your responsibility to publish reproducible findings or deliver valid data to your customers. Even implementing some of the suggestions mentioned above could give your research a significant boost in reproducibility. References 1 Baker M. 1,500 Scientists Lift the Lid on Reproducibility. Nature. 2016. 2 Lundholt B, Pagliaro L, Scudder K. A Sample Technique for Reducing Edge Effect in Cell-Based Assays. J. Biomol. Screen. 2003; 8: 566-70. Getting on with Discovery 866-513-1894 | www.astartebio.com © Astarte Biologics, Inc.